Physicians' Cancer Chemotherapy Drug Manual 2004: Spiral
0763748374
9780763748371
Description:
This manual summarizes the primary indications, drug doses and schedules, toxicities, and special considerations for 100 drugs currently used in clinical cancer therapy, listed alphabetically according to their generic name. Two smaller chapters recommend dose modifications for liver and renal dysfunctions, and outline drug regimens for solid tumors and hematologic malignancies. The 2004 edition adds five new agents. Spiral binding. The CD-ROM is a digital version of the book. Annotation ©2004 Book News, Inc., Portland, OR (booknews.com)
Best prices to buy, sell, or rent ISBN 9780763748371
Related Books
- 1
- 2
- 3
- 4
- Physicians' Cancer Chemotherapy Drug Manual 2003Chu, EdwardEdition:Book and CD-ROMISBN-13:9780763721312
- Physician's Cancer Chemotherapy Drug Manual 2001DeVita, Vincent T.; Chu, Edward, M.D.Edition:First EditionISBN-13:9780763714482
- Physician's Cancer Chemo Drug Manual Sub to 1448-8CHUEdition:1 EdISBN-13:9780763714505
- Physicians' Cancer Chemotherapy Drug Manual 2002Chu, EdwardEdition:First EditionISBN-13:9780763719739
- Physicians' Cancer Chemotherapy Drug Manual 2003Chu, EdwardEdition:Book and CD-ROMISBN-13:9780763721312
- Physician's Cancer Chemotherapy Drug Manual 2001DeVita, Vincent T.; Chu, Edward, M.D.Edition:First EditionISBN-13:9780763714482
Frequently Asked Questions about Physicians' Cancer Chemotherapy Drug Manual 2004: Spiral
The price for the book starts from $16.98 on Amazon and is available from 3 sellers at the moment.
If you’re interested in selling back the Physicians' Cancer Chemotherapy Drug Manual 2004: Spiral book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Physicians' Cancer Chemotherapy Drug Manual 2004: Spiral book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.